National Health Investors, Inc. (NYSE:NHI) Shares Sold by Sumitomo Mitsui Trust Holdings Inc.

Sumitomo Mitsui Trust Holdings Inc. reduced its holdings in National Health Investors, Inc. (NYSE:NHI) by 3.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 371,202 shares of the real estate investment trust’s stock after selling 11,931 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about 0.86% of National Health Investors worth $20,732,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Van ECK Associates Corp grew its holdings in National Health Investors by 4.3% in the third quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock valued at $251,000 after purchasing an additional 202 shares during the period. Sound Income Strategies LLC grew its holdings in National Health Investors by 33.5% in the fourth quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock valued at $51,000 after purchasing an additional 230 shares during the period. Atria Wealth Solutions Inc. lifted its position in shares of National Health Investors by 3.4% in the third quarter. Atria Wealth Solutions Inc. now owns 7,841 shares of the real estate investment trust’s stock valued at $403,000 after acquiring an additional 261 shares in the last quarter. State of Alaska Department of Revenue lifted its position in shares of National Health Investors by 1.4% in the third quarter. State of Alaska Department of Revenue now owns 19,817 shares of the real estate investment trust’s stock valued at $1,017,000 after acquiring an additional 268 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. lifted its position in shares of National Health Investors by 0.9% in the third quarter. Nomura Asset Management Co. Ltd. now owns 47,540 shares of the real estate investment trust’s stock valued at $2,442,000 after acquiring an additional 420 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford bought 10,000 shares of National Health Investors stock in a transaction on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the transaction, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 8.21% of the company’s stock.

National Health Investors Stock Performance

Shares of National Health Investors stock opened at $62.35 on Tuesday. National Health Investors, Inc. has a one year low of $47.54 and a one year high of $62.93. The company has a market cap of $2.71 billion, a price-to-earnings ratio of 19.92 and a beta of 0.95. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27. The business’s 50 day moving average price is $58.97 and its 200 day moving average price is $55.43.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 3rd. Investors of record on Thursday, March 28th will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a yield of 5.77%. National Health Investors’s payout ratio is 115.02%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on NHI. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Truist Financial raised their target price on National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research report on Thursday, April 4th. Wedbush raised their target price on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price on the stock in a research report on Tuesday, March 12th. Finally, Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, National Health Investors has a consensus rating of “Hold” and a consensus target price of $60.50.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.